Producción CientíficaAtherogenesis is the consequence of a variety of effector mechanisms rather than the result of a single functional molecule. In this connection, type IIA secretory phospholipase A2 (sPLA2) is an acute-phase reactant, which accumulates in atherosclerotic arterial walls, elicits several effects on monocytes, and has been related to the development of atherosclerosis. CD40/CD40 ligand pair is also a strong proatherogenic system. sPLA2 produced an increase of the surface expression of CD40 in THP-1 monocytes and enhanced the effect of CD40 ligation on the expression of both Fas and FasL, thus indicating the existence of a positive cooperation between sPLA2 and different elements of the TNF-receptor superfamily. Activation o...
Experimental and clinical evidence indicates that secretory phospholipase A2 group IIA (sPLA2-IIA) c...
Abstract: Secretory nonpancreatic group IIA phospholipase A2 (sPLA2), a lipolytic enzyme found in pl...
In rat mesangial cells, exogenously added secreted phospholipases A2 (sPLA2s) potentiate the express...
Producción CientíficaType IIA secretory phospholipase A2 (sPLA2) is an acute-phase reactant that pla...
Producción CientíficaAims: Human atherosclerotic plaques express markers of macrophage/dendritic cel...
Dimitar Divchev, Bernhard SchiefferDepartment of Cardiology and Angiology, Medizinische Hochschule H...
Secreted phospholipases A2 (sPLA2s) are enzymes detected in serum and biological fluids of patients ...
Resumen del póster presentado presentado al CIBERDEM Annual Meeting, celebrado en Cerdanyola del Val...
In macrophages and other major immunoinflammatory cells, two phospholipase A2 (PLA2) enzymes act in ...
Secretory phospholipases A2 (sPLA2) are enzymes released during inflammatory reactions. These molecu...
Inflammatory mediators contribute significantly to the induction and progression of cardiovascular d...
Inflammatory reactions contribute to the pathogenesis of cardiovascular conditions such as atheroscl...
Secretory phospholipases A2 (sPLA2) are released in the blood of patients with various inflammatory ...
Atherosclerosis is not only a lipid-driven disease but it is an intricate process that also involves...
Experimental and clinical evidence indicates that secretory phospholipase A2 group IIA (sPLA2-IIA) c...
Abstract: Secretory nonpancreatic group IIA phospholipase A2 (sPLA2), a lipolytic enzyme found in pl...
In rat mesangial cells, exogenously added secreted phospholipases A2 (sPLA2s) potentiate the express...
Producción CientíficaType IIA secretory phospholipase A2 (sPLA2) is an acute-phase reactant that pla...
Producción CientíficaAims: Human atherosclerotic plaques express markers of macrophage/dendritic cel...
Dimitar Divchev, Bernhard SchiefferDepartment of Cardiology and Angiology, Medizinische Hochschule H...
Secreted phospholipases A2 (sPLA2s) are enzymes detected in serum and biological fluids of patients ...
Resumen del póster presentado presentado al CIBERDEM Annual Meeting, celebrado en Cerdanyola del Val...
In macrophages and other major immunoinflammatory cells, two phospholipase A2 (PLA2) enzymes act in ...
Secretory phospholipases A2 (sPLA2) are enzymes released during inflammatory reactions. These molecu...
Inflammatory mediators contribute significantly to the induction and progression of cardiovascular d...
Inflammatory reactions contribute to the pathogenesis of cardiovascular conditions such as atheroscl...
Secretory phospholipases A2 (sPLA2) are released in the blood of patients with various inflammatory ...
Atherosclerosis is not only a lipid-driven disease but it is an intricate process that also involves...
Experimental and clinical evidence indicates that secretory phospholipase A2 group IIA (sPLA2-IIA) c...
Abstract: Secretory nonpancreatic group IIA phospholipase A2 (sPLA2), a lipolytic enzyme found in pl...
In rat mesangial cells, exogenously added secreted phospholipases A2 (sPLA2s) potentiate the express...